We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.55B
AUM Growth
-$172M
Cap. Flow
+$97.5M
Cap. Flow %
1.76%
Top 10 Hldgs %
18.08%
Holding
1,627
New
142
Increased
661
Reduced
568
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Financials 11.7%
3 Healthcare 10.28%
4 Industrials 8.25%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJS icon
1351
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$202K ﹤0.01%
+1,970
New +$201K
SUM
1352
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$202K ﹤0.01%
6,622
+1,537
+30% +$51.2K
SIVB
1353
DELISTED
SVB Financial Group
SIVB
$202K ﹤0.01%
361
-2,511
-87% -$1.52M
PACB icon
1354
Pacific Biosciences
PACB
$460M
$201K ﹤0.01%
22,125
SCHK icon
1355
Schwab 1000 Index ETF
SCHK
$5.68B
$201K ﹤0.01%
9,138
MGRC icon
1356
McGrath RentCorp
MGRC
$2.81B
$200K ﹤0.01%
+2,350
New +$187K
NAD icon
1357
Nuveen Quality Municipal Income Fund
NAD
$2.73B
$200K ﹤0.01%
14,981
+33
+0.2% +$474
AVK
1358
Advent Convertible and Income Fund
AVK
$543M
$199K ﹤0.01%
13,024
+1,027
+9% +$16.1K
BFK
1359
DELISTED
BlackRock Municipal Income Trust
BFK
$199K ﹤0.01%
16,345
+1,271
+8% +$17.3K
BGY icon
1360
BlackRock Enhanced International Dividend Trust
BGY
$521M
$199K ﹤0.01%
34,526
-2,739
-7% -$16.3K
DMO
1361
Western Asset Mortgage Opportunity Fund
DMO
$118M
$190K ﹤0.01%
14,237
+205
+1% +$2.94K
JRO
1362
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$189K ﹤0.01%
18,684
+3,949
+27% +$39.5K
AMRS
1363
DELISTED
Amyris Inc.
AMRS
$188K ﹤0.01%
43,122
-12,763
-23% -$57.3K
UXIN
1364
Uxin Ltd
UXIN
$308M
$187K ﹤0.01%
1,830
BCAT icon
1365
BlackRock Capital Allocation Term Trust
BCAT
$1.64B
$185K ﹤0.01%
11,145
-1,000
-8% -$17.6K
SIRI icon
1366
SiriusXM
SIRI
$10.4B
$183K ﹤0.01%
2,759
+1
+0% +$63
NRK icon
1367
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$903M
$180K ﹤0.01%
14,869
-8,425
-36% -$107K
JRS icon
1368
Nuveen Real Estate Income Fund
JRS
$250M
$176K ﹤0.01%
14,884
+4,522
+44% +$52.4K
FEI
1369
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$176K ﹤0.01%
21,339
MMU
1370
Western Asset Managed Municipals Fund
MMU
$550M
$175K ﹤0.01%
15,045
-1,306
-8% -$16K
BOE icon
1371
BlackRock Enhanced Global Dividend Trust
BOE
$675M
$173K ﹤0.01%
15,231
+2,602
+21% +$30K
FAM
1372
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$173K ﹤0.01%
23,147
+123
+0.5% +$1.03K
TRHC
1373
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$173K ﹤0.01%
30,019
+740
+3% +$6.64K
HUGS
1374
DELISTED
USHG Acquisition Corp.
HUGS
$173K ﹤0.01%
17,100
+1,300
+8% +$13.3K
BNGO icon
1375
Bionano Genomics
BNGO
$12.2M
$171K ﹤0.01%
110
-50
-31% -$67.5K

Similar funds

Oppenheimer & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Oppenheimer & Co held 1,627 positions worth $5.55B, down 3% from $5.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q1 2022 filing shows 142 new, 661 increased, 568 reduced and 164 closed positions. Its largest new stake was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M. The largest sale was Apple, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q1 2022 buy was abrdn Physical Gold Shares ETF: 689,377 shares worth $12.8M.
  • Oppenheimer & Co added most to Citigroup in Q1 2022, an estimated $12.9M increase.
  • Oppenheimer & Co's biggest Q1 2022 reduction was Apple, cutting an estimated $18M.
  • Oppenheimer & Co fully exited Xilinx Inc in Q1 2022, selling an estimated $7.92M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.55B portfolio in Q1 2022.
  • Oppenheimer & Co opened 142 new positions and closed 164 in Q1 2022.
  • Oppenheimer & Co's portfolio value fell 3% quarter-over-quarter to $5.55B.

Based on Oppenheimer & Co's 13F filing for Q1 2022, filed 12 May 2022.